0001209191-23-041673.txt : 20230706
0001209191-23-041673.hdr.sgml : 20230706
20230706183754
ACCESSION NUMBER: 0001209191-23-041673
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230701
FILED AS OF DATE: 20230706
DATE AS OF CHANGE: 20230706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chin Mark
CENTRAL INDEX KEY: 0001734389
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38800
FILM NUMBER: 231074810
MAIL ADDRESS:
STREET 1: 20 BERKELEY SQUARE, MAYFAIR
CITY: LONDON
STATE: X0
ZIP: W1J 6EQ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Harpoon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001708493
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473458693
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 131 OYSTER POINT BOULEVARD
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-443-7400
MAIL ADDRESS:
STREET 1: 131 OYSTER POINT BOULEVARD
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-07-01
0
0001708493
Harpoon Therapeutics, Inc.
HARP
0001734389
Chin Mark
C/O HARPOON THERAPEUTICS, INC.
131 OYSTER POINT BOULEVARD, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
0
Common Stock
2023-07-01
4
A
0
18656
0.00
A
36941
D
Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). The fully vested RSUs were granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $12,500.
/s/ Frank J. Lanza, Attorney-in-Fact
2023-07-06